Navigation Links
Trius to Participate in Antibiotics Panel Discussion at Citi's 5th Annual Biotech Day
Date:10/4/2010

SAN DIEGO, Oct. 4 /PRNewswire/ -- Trius Therapeutics, Inc. (Nasdaq: TSRX) announced today that Jeffrey Stein, Ph.D., President and Chief Executive Officer of Trius Therapeutics, will participate in a panel discussion on antibiotic drug development at Citi's 5th Annual Biotech Day.  The panel titled, How to Kill Superbugs: Novel Antibiotics to Hit Drug Resistant Bacteria, will take place at 2:00 p.m. ET on Tuesday, October 5th at the Westin Waterfront Hotel in Boston.

About Trius Therapeutics

Trius Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics for serious, life-threatening infections. The company's lead product candidate, torezolid phosphate, is an IV and orally administered second generation oxazolidinone in Phase 3 clinical development for the treatment of acute bacterial skin and skin structure infections (ABSSSI), the first such trial to be initiated under a Special Protocol Assessment (SPA). In addition to the company's torezolid phosphate clinical program, it is currently conducting two preclinical programs using its proprietary discovery platform to develop antibiotics to treat infections caused by gram-negative bacteria. For more information, visit www.triusrx.com.


'/>"/>
SOURCE Trius Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Trius Awarded $28 Million Contract to Develop Novel Antibiotics
2. Trius Appoints Don Batts and Ralph Corey to Clinical Advisory Board
3. Trius Therapeutics Awarded U.S. Department of Defense Contract to Develop Novel Antibiotics
4. Trius Therapeutics Reports 2010 Second Quarter Results
5. ATS Medical to Participate at the Fourth Annual Noble Financial Equity Conference
6. Boston Scientific to Participate in UBS Global Life Sciences Conference
7. Endovascular Forum Inc.s President to Participate in Health 2.0 Northeast Panel
8. Sinovac to Participate in Two Upcoming Investor Conferences
9. Simcere Pharmaceutical Group to Participate in Morgan Stanley Seventh Annual Asia Pacific Summit 2008
10. B. Braun Directors Participate at First ISMP National Smart Pump Safety Summit
11. Boston Scientific to Participate in Piper Jaffray Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... , Jan. 24, 2017 Vivonoetics Inc., ... announced today that in partnership with Great Lakes ... to the Roche FIREFISH study.    ... respiratory insufficiency due to progressive respiratory muscle weakness ... the spinal cord. This weakness results in ineffective ...
(Date:1/24/2017)... Jan. 24, 2017 Reha Technology USA ... Boston . The need for Robotic technology in ... is widely accepted in the surgical space. Project Walk – ... to traditional therapy and adding technology to their continuum of care. ... higher gait training repetitions which has been shown to improve gait ...
(Date:1/24/2017)... , Jan. 24, 2017 Relmada Therapeutics, Inc. ... the treatment of central nervous system (CNS) diseases, is ... and a recent meeting with the U.S. Food and ... the clinical development of LevoCap ER (REL-1015, levorphanol extended ... new drug application (NDA) filing is achievable.   ...
(Date:1/24/2017)... 2017  Applied BioMath ( www.appliedbiomath.com ), ... drug research and development, today announced their ... and Next-Generation Biologics: Innovative Strategies for Optimally ... PhD, Senior Scientist at Applied BioMath will ... mechanistic determinants of antibody drug-conjugate pharmacokinetics using ...
Breaking Biology Technology:
(Date:12/22/2016)... YORK , December 22, 2016 ... provider of secure solutions for the e-Government, Public Safety, HealthCare, and ... subsidiary of SuperCom, has been selected to implement and deploy a ... in Northern California , further expanding its presence ... ...
(Date:12/16/2016)...   IdentyTechSolutions America LLC , a leading ... and a cutting-edge manufacturer of software and hardware ... seamless, integrated solutions that comprise IDT biometric readers ... provide IdentyTech,s customers with combined physical identification and ... and theft. "We are proud to ...
(Date:12/15/2016)... 15, 2016   WaferGen Bio-systems, Inc. (NASDAQ: ... company, announced today that on December 13, 2016, it ... The Nasdaq Stock Market LLC which acknowledged that, as ... WaferGen,s common stock had been at $1.00 or greater ... compliance with Listing Rule 5550(a)(2) of the Nasdaq Stock ...
Breaking Biology News(10 mins):